Stepping Up to the Plate

To combat the growing threat of antimicrobial resistance, we need a new slate of drugs.

Several entities are committed to fostering the research into antimicrobial resistance. With so many cooks in the kitchen, the WHO has a leading role to play in coordinating R&D efforts to create drugs that are affordable, accessible, and used appropriately, write the WHO’s Peter Beyer and colleagues.

Guided by WHO’s Ebola response playbook, the agency will maintain its priority pathogen list of antibiotic-resistant bacteria, and continue to develop Target Product Profiles to identify the ideal characteristics of would-be vaccines.

The Lancet

Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top